CompaniesAngioGenetics

AngioGenetics

defunct

About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

160

By Phase

PHASE3: 1

By Status

UNKNOWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT02928094Lead Sponsor

Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia

160 participants

Started: Jan 1, 2023 · Completed: Dec 31, 2024

AngioGenetics | Biotech Hunter | Biotech Hunter